Share
24 March 202021.39 Green light from the Medicines Agency to the use, outside of the protocols, of the combination of Lopinavir and Ritonavir, already used against the HIV virus. "A first randomized study on Covid-19 patients - emphasizes Aifa- carried out in Wuhan (China) involving 199 patients did not show any difference in time to clinical improvement and mortality". A result that for AIFA should also be assessed under other parameters and for this reason, medicines for hospital use can also be used at home.Aifa: virus, ok for antiretrovirals
2020-03-24T20:45:39.160Z
21.39 Green light from the Medicines Agency to the use, outside the protocols, of the combination of Lopinavir and Ritonavir, already used against the HIV virus. "A first randomized study on Covid-19 patients - emphasizes Aifa- carried out in Wuhan (China) involving 199 patients did not show any difference in time to clinical improvement and mortality". A result that for AIFA should also be assessed under other parameters and for this reason, medicines for hospital use can also be used at home.
Source: rainews